🥇 First rule of investing? Know when to save! Up to 55% off Investing Pro before BLACK FRIDAYCLAIM SALE

Minerva Neurosciences Inc (NERV)

NASDAQ
Currency in USD
2.330
+0.010(+0.43%)
Real-time Data
NERV Scorecard
Full Analysis
Stock has taken a big hit over the last week
Fair Value
Day's Range
2.3102.400
52 wk Range
2.26013.490
Prev. Close
2.32
Open
2.31
Day's Range
2.31-2.4
52 wk Range
2.26-13.49
Volume
4,710
Average Volume (3m)
17,978
1-Year Change
-55.73%
Book Value / Share
Unlock
Fair Value
Unlock
Fair Value Upside
Unlock
NERV Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
5.000
Upside
+114.592%
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins
Show more

Minerva Neurosciences Company Profile

Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone (MIN-101) for the treatment of negative symptoms in patients with schizophrenia, currently submitted an New Drug Application (NDA); and MIN-301, a soluble recombinant form of the neuregulin-1b1 protein for the treatment of Parkinson’s disease and other neurodegenerative disorders. The company has a license agreement with Mitsubishi Tanabe Pharma Corporation to develop, sell, and import roluperidone globally excluding Asia. Minerva Neurosciences, Inc. was incorporated in 2007 and is based in Burlington, Massachusetts.

Compare NERV to Peers and Sector

Metrics to compare
NERV
Peers
Sector
Relationship
P/E Ratio
−4.9x−3.1x−0.6x
PEG Ratio
−0.05−0.020.00
Price/Book
−0.7x3.0x2.6x
Price / LTM Sales
-61.9x3.3x
Upside (Analyst Target)
115.5%232.9%45.3%
Fair Value Upside
Unlock−1.5%6.1%Unlock

FAQ

What Is the Minerva Neurosciences (NERV) Stock Price Today?

The Minerva Neurosciences stock price today is 2.33.

What Stock Exchange Does Minerva Neurosciences Trade On?

Minerva Neurosciences is listed and trades on the NASDAQ stock exchange.

What Is the Stock Symbol for Minerva Neurosciences?

The stock symbol for Minerva Neurosciences is "NERV."

What Is the Minerva Neurosciences Market Cap?

As of today, Minerva Neurosciences market cap is 16.29M.

What is Minerva Neurosciences Earnings Per Share?

The Minerva Neurosciences EPS is -0.437.

What Is the Next Minerva Neurosciences Earnings Date?

Minerva Neurosciences will release its next earnings report on 17 Mar 2025.

From a Technical Analysis Perspective, Is NERV a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.